Comments

Prelude Therapeutics

PRLDNASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$2.44
-0.01-0.41%
At Close: -
$2.50
0.062.26%
After Hours: 7:58 PM EDT
15 minutes delayed
Prelude Therapeutics (PRLD) ForecastNewsEarnings

Guidance

DividendsAnalyst RatingsInsider TradesShort Interest

Prelude Therapeutics (NASDAQ:PRLD) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for Prelude Therapeutics (PRLD)?

A

There have been no specific sales or earnings guidance reported for Prelude Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch